NASDAQ · Financial Statements
Aethlon Medical, Inc. (AEMD) Financial Statements
$6.10
NASDAQ: AEMD
Market Cap $3.21M
Overview Financials Dividend Aethlon Medical, Inc. most recently reported annual revenue of $0, net profit of $-7.0M. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.
Annual Financials (USD)
Metric 2022 2023 2024 2025 2026 Revenue $0 $1.0M $0 $0 $0 Operating Profit $-10.0M $-12.0M $-13.0M $-9.0M $-7.0M Net Profit $-10.0M $-12.0M $-12.0M $-13.0M $-7.0M EPS $-564.68 $-468.60 $-388.67 $-85.77 $-10.61 Op Margin -3542.5% -2072.1% — — —
Balance Sheet (USD)
Metric 2022 2023 2024 2025 2026 Total Assets $19.0M $18.0M $8.0M $7.0M $6.0M Total Liabilities $2.0M $2.0M $2.0M $2.0M $1.0M Cash $17.0M $15.0M $5.0M $6.0M $5.0M Borrowings $1.0M $1.0M $1.0M $1.0M $0
Cash Flow (USD)
Metric 2022 2023 2024 2025 2026 Operating Cash Flow $-10.0M $-11.0M $-10.0M $-8.0M $-7.0M Investing Cash Flow $-1.0M $-2.0M $-1.0M $0 $0 Financing Cash Flow $0 $0 $0 $4.0M $0 Net Cash Flow $7.0M $-3.0M $-9.0M $0 $0 Free Cash Flow $-10.0M $-11.0M $-10.0M $-8.0M $-7.0M
Valuation & Return Ratios
Metric Value PEG Ratio 0.00 EV / EBITDA 0.18 FCF Yield -56249.98% Quick Ratio 5.42 Interest Coverage -492.66 Return 1Y -94.27% Return 3Y -99.80% Return 5Y -99.98%
Screens featuring this stock